Daewon Pharmaceutical Co., Ltd. (KRX:003220)

South Korea · Delayed Price · Currency is KRW

10,720

-90 (-0.83%)

Apr 30, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Restrictions	542.98B	536.09B	500.70B	452.80B	339.08B
Restrictions Growth	1.29%	7.07%	10.58%	33.54%	10.68%
Cosmetics	30.07B	34.47B	-	-	-
Cosmetics Growth	-12.77%	-	-	-	-
Health Functional Food	36.07B	28.06B	26.48B	25.86B	13.07B
Health Functional Food Growth	28.55%	5.96%	2.39%	97.94%	-
Consolidated Adjustments	-4.17B	-958.60M	-521.20M	-1.07B	-155.22M
Other Sectors	481.72M	504.20M	-	-	-
Other Sectors Growth	-4.46%	-	-	-	-
Hearing Aid	-	-	295.28M	1.29B	2.19B
Hearing Aid Growth	-	-	-77.04%	-41.25%	-0.50%
Total	605.43B	598.16B	526.95B	478.88B	354.18B
Total Growth	1.22%	13.51%	10.04%	35.21%	14.81%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea	584.75B	566.57B	516.43B	467.17B	343.62B
South Korea Growth	3.21%	9.71%	10.54%	35.96%	14.86%
Overseas	20.68B	31.59B	10.53B	11.71B	10.56B
Overseas Growth	-34.54%	200.16%	-10.15%	10.93%	13.08%
Total	605.43B	598.16B	526.95B	478.88B	354.18B
Total Growth	1.22%	13.51%	10.04%	35.21%	14.81%

Source: S&P Global Market Intelligence.